CORMEDIX INC. (CRMD)

Every figure this model derived for CRMD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 3,516,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 256,692,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 480,554,000 AssetsCurrent 2026-06-30
current liabilities 187,396,000 LiabilitiesCurrent 2026-06-30
equity 460,833,000 StockholdersEquity 2026-06-30
interest expense 2,817,000 InterestPaidNet 2026-06-30
ocf 253,937,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 229,358,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 16,320,565 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CRMD on one particular measure came for.

RatioValue
cash operating margin110.94
current ratio2.56
current ratio reported2.56
deferred revenue growth-80.0
dilution pct36.44
ebit yoy340.08
fcf margin109.18
growth cv1.98
interest cover77.05
operating margin94.63
owner earnings margin102.07
revenue growth191.0
revenue growth per share113.28
rule of 40285.63
sbc pct revenue7.12

What to be careful about

What this model itself distrusts about CRMD's figures. Written by the derivation as it ran, not added afterwards.